Antimalarials in Development in 2014
Authors:
- 23 October 2014
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 114 (22) , 11221-11241
Abstract
No abstract availableFunding Information
- American Lebanese Syrian Associated Charities
This publication has 189 references indexed in Scilit:
- Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone AntimalarialsCell Host & Microbe, 2013
- Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial AgentsJournal of Medicinal Chemistry, 2012
- Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate PotentialJournal of Medicinal Chemistry, 2011
- Lead Optimization of Aryl and Aralkyl Amine-Based Triazolopyrimidine Inhibitors ofPlasmodium falciparumDihydroorotate Dehydrogenase with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2011
- Optimization of endochin-like quinolones for antimalarial activityExperimental Parasitology, 2011
- Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2009
- Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors with Potent and Selective Activity against the Malaria Parasite Plasmodium falciparumJournal of Medicinal Chemistry, 2008
- A drug-selected Plasmodium falciparum lacking the need for conventional electron transportMolecular and Biochemical Parasitology, 2008
- Antimalarial quinolones: Synthesis, potency, and mechanistic studiesExperimental Parasitology, 2008
- Analysis of Flavin Oxidation and Electron-Transfer Inhibition in Plasmodium falciparum Dihydroorotate DehydrogenaseBiochemistry, 2008